.png){kind=icon}
Return
Visualizing drug binding interactions using microcrystal electron diffraction
.png){kind=icon}
OA
AI
DOI：10.1038/s42003-020-01155-1.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Visualizing ligand binding interactions is important for structure-based drug design and fragment-based screening methods. Rapid and uniform soaking with potentially reduced lattice defects make small macromolecular crystals attractive targets for studying drug binding using microcrystal electron diffraction (MicroED). However, so far no drug binding interactions could unambiguously be resolved by electron diffraction alone. Here, we use MicroED to study the binding of a sulfonamide inhibitor to human carbonic anhydrase isoform II (HCA II). We show that MicroED data can efficiently be collected on a conventional transmission electron microscope from thin hydrated microcrystals soaked with the clinical drug acetazolamide (AZM). The data are of high enough quality to unequivocally fit and resolve the bound inhibitor. We anticipate MicroED can play an important role in facilitating in-house fragment screening for drug discovery, complementing existing methods in structural biology such as X-ray and neutron diffraction. Clabbers et al. utilize MicroED to present the structure of both apo and inhibitor-bound human carbonic anhydrase II at a high resolution to clearly identify the interaction of the inhibitor, acetazolamide. This method eases the difficulty of both crystallizing the protein and soaking the inhibitor in a smaller protein crystal.
Keywords:
CARBONIC-ANHYDRASE II
NEUTRON STRUCTURE
PROTEIN CRYSTALS
DATA-COLLECTION
ATOMIC DETAILS
CRYSTALLOGRAPHY
DISCOVERY
REFINEMENT
SOFTWARE
SOLVENT
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
5.1
Papers:
1.0W
Citations:
3.2W
Organization
Cited Papers
.png){kind=icon}
ShareSaveShareSaveShareSaveShareSave
View more